These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18240249)

  • 1. Successful treatment of resistant pseudogout with anakinra.
    McGonagle D; Tan AL; Madden J; Emery P; McDermott MF
    Arthritis Rheum; 2008 Feb; 58(2):631-3. PubMed ID: 18240249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1β blockade improves signs and symptoms of chronic calcium pyrophosphate crystal arthritis resistant to treatment.
    Diamantopoulos AP; Brodin C; Hetland H; Haugeberg G
    J Clin Rheumatol; 2012 Sep; 18(6):310-1. PubMed ID: 22832289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with a Veterans Affairs Medical Center.
    Desmarais J; Chu CQ
    J Rheumatol; 2019 Jul; 46(7):748-750. PubMed ID: 30442822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure.
    Announ N; Palmer G; Guerne PA; Gabay C
    Joint Bone Spine; 2009 Jul; 76(4):424-6. PubMed ID: 19289295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 inhibition with anakinra in a patient with refractory gout.
    Singh D; Huston KK
    J Clin Rheumatol; 2009 Oct; 15(7):366. PubMed ID: 20009976
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
    Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
    Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Chevalier X; Goupille P; Beaulieu AD; Burch FX; Bensen WG; Conrozier T; Loeuille D; Kivitz AJ; Silver D; Appleton BE
    Arthritis Rheum; 2009 Mar; 61(3):344-52. PubMed ID: 19248129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudogout in 3 patients with presumed therapy-resistant rheumatoid arthritis].
    Vergunst CE; Tak PP
    Ned Tijdschr Geneeskd; 2005 Apr; 149(14):773-7. PubMed ID: 15835631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease.
    Lovell DJ; Bowyer SL; Solinger AM
    Arthritis Rheum; 2005 Apr; 52(4):1283-6. PubMed ID: 15818707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schnitzler's syndrome: successful treatment with anakinra.
    Crouch R; Akhras V; Sarkany R
    Australas J Dermatol; 2007 Aug; 48(3):178-81. PubMed ID: 17680970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra].
    Livory M; Wechsler J; Revuz J; Bagot M; Chevalier X; Poszepczynska-Guigné E
    Ann Dermatol Venereol; 2008 Dec; 135(12):839-42. PubMed ID: 19084694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
    Vordenbäumen S; Ostendorf B; Sander O; Richter J; Schneider M
    Ann Rheum Dis; 2009 Mar; 68(3):450-1. PubMed ID: 19213754
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids.
    Bruck N; Suttorp M; Kabus M; Heubner G; Gahr M; Pessler F
    J Clin Rheumatol; 2011 Jan; 17(1):23-7. PubMed ID: 21169853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient.
    Mitroulis I; Papadopoulos VP; Konstantinidis T; Ritis K
    Neth J Med; 2008 Dec; 66(11):489-91. PubMed ID: 19075317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
    Ottaviani S; Brunier L; Sibilia J; Maurier F; Ardizzone M; Wendling D; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Mar; 80(2):178-82. PubMed ID: 23022422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra's efficacy is variable in refractory gout: report of ten cases.
    Chen K; Fields T; Mancuso CA; Bass AR; Vasanth L
    Semin Arthritis Rheum; 2010 Dec; 40(3):210-4. PubMed ID: 20494407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial granulomatous drug reaction to anakinra.
    Regula CG; Hennessy J; Clarke LE; Adams DR; Ioffreda MD; Graber EM; Helm KF
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S25-7. PubMed ID: 18625373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra].
    Dybowski F; Jakobs B; Altmeyer P; Braun J
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1863-6. PubMed ID: 16915547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.